Related references
Note: Only part of the references are listed.Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition
Roger A. Habets et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies
Claudia Sorrentino et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2019)
Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy
Elisabeth Silkenstedt et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma
Liang Mao et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Leukemia-specific delivery of mutant NOTCH1 targeted therapy
Giovanni Roti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors
R. Ferrarotto et al.
ANNALS OF ONCOLOGY (2018)
Inhibition of Notch signaling pathway using gamma-secretase inhibitor delivered by a low dose of Triton-X100 in cultured oral cancer cells
Aklima Nasrin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
Stefano Baldoni et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation
Maria Di Bari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+breast cancer cell proliferation and stem cell survival
Andrew Baker et al.
ONCOGENE (2018)
Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway
Long Hai et al.
CELL DEATH & DISEASE (2018)
First-in-human phase 1-2A study of CB-103, an oral Protein-Protein Interaction Inhibitor targeting pan-NOTCH signalling in advanced solid tumors and blood malignancies.
Jose Manuel Perez Garcia et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun
X. Xie et al.
ONCOGENE (2017)
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
Marzia A. Locatelli et al.
ONCOTARGET (2017)
Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations
Brian J. McMillan et al.
GLYCOBIOLOGY (2017)
Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma
Wei Xiao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma
Katherine M. Morgan et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Targeted inhibition of Notch1 gene enhances the killing effects of Paclitaxel on triple-negative breast cancer cells
Yu-Fu Zhou et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2017)
MicroRNA-145 induces apoptosis of glioma cells by targeting BNIP3 and Notch signaling
Yan Du et al.
ONCOTARGET (2017)
Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy
Hanqiu Zheng et al.
CANCER CELL (2017)
γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct
Yong Ran et al.
EMBO MOLECULAR MEDICINE (2017)
The Notch-1 receptor in prostate tumorigenesis
Rebecca O'Brien et al.
CANCER TREATMENT REVIEWS (2017)
Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma
P. Bettinsoli et al.
BMC CANCER (2017)
Endothelial Notch1 Activity Facilitates Metastasis
Elfriede Wieland et al.
CANCER CELL (2017)
miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer
Lei Jiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Anticancer effect of eupatilin on glioma cells through inhibition of the Notch-1 signaling pathway
Yawei Wang et al.
MOLECULAR MEDICINE REPORTS (2016)
The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance
Luyao Liu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
Targeting Notch to overcome radiation resistance
Sanaz Yahyanejad et al.
ONCOTARGET (2016)
Notch1 controls cell chemoresistance in small cell lung carcinoma cells
Wael Abdo Hassan et al.
THORACIC CANCER (2016)
Paeoniflorin inhibits proliferation and invasion of breast cancer cells through suppressing Notch-1 signaling pathway
Qiang Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours
D. Mahalingam et al.
BRITISH JOURNAL OF CANCER (2016)
A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
Shubham Pant et al.
EUROPEAN JOURNAL OF CANCER (2016)
The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia
Rui D. Mendes et al.
HAEMATOLOGICA (2016)
Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism
Emma Phillips et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Cancer stem cell signaling pathways
William H. Matsui
MEDICINE (2016)
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
Chiara Ambrogio et al.
NATURE MEDICINE (2016)
Role of non-coding sequence variants in cancer
Ekta Khurana et al.
NATURE REVIEWS GENETICS (2016)
The clerodane diterpene casearin J induces apoptosis of T-ALL cells through SERCA inhibition, oxidative stress, and interference with Notch1 signaling
C. De Ford et al.
CELL DEATH & DISEASE (2016)
Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin
Michihiro Ono et al.
ONCOTARGET (2016)
Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain
Hyeok Gu Kang et al.
ONCOTARGET (2016)
The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia
Rui D. Mendes et al.
HAEMATOLOGICA (2016)
BMS-871: A novel orally active pan-Notch inhibitor as an anticancer agent
Weifang Shan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Targeting the Notch pathway: A potential therapeutic approach for desmoid tumors
Hui Shang et al.
CANCER (2015)
Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters
Chen-Guo Zheng et al.
CANCER BIOMARKERS (2015)
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
Elena Gabriela Chiorean et al.
CLINICAL CANCER RESEARCH (2015)
Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome
Cristina L. Ronchi et al.
ENDOCRINE-RELATED CANCER (2015)
Notch-1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer
Alexander W. Fender et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy
Daniel L. Abravanel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
NOTCH1 and FBXW7 Mutations Favor Better Outcome in Pediatric South Indian T-Cell Acute Lymphoblastic Leukemia
Valliyammai Natarajan et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2015)
HES1-mediated inhibition of Notchl signaling by a Gemini vitamin D analog leads to decreased CD44+/CD24-/low tumor-initiating subpopulation in basal-like breast cancer
Jae Young So et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma
Steven Koprowski et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Prognostic value of Notch-1 expression in hepatocellular carcinoma: a meta-analysis
Tao Wu et al.
ONCOTARGETS AND THERAPY (2015)
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
Cristina Papayannidis et al.
BLOOD CANCER JOURNAL (2015)
Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
Jia Ma et al.
ONCOTARGET (2015)
A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors
Ankur Sharma et al.
SCIENTIFIC REPORTS (2015)
New, Tolerable gamma-Secretase Inhibitor Takes Desmoid Down a Notch
Dennis P. M. Hughes et al.
CLINICAL CANCER RESEARCH (2015)
A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral gamma-Secretase Inhibitor PF-03084014
Wells A. Messersmith et al.
CLINICAL CANCER RESEARCH (2015)
Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells
Shingo Tanaka et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model
P. Yu et al.
LEUKEMIA (2015)
Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
Xun Yuan et al.
PLOS ONE (2015)
Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
Xiaoqun Dong et al.
ONCOTARGET (2015)
Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis
Xun Yuan et al.
SCIENTIFIC REPORTS (2015)
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
Erin L. Hayes et al.
BREAST CANCER RESEARCH (2015)
Hyaluronic acid-chitosan nanoparticles for co-delivery of M1R-34a and doxorubicin in therapy against triple negative breast cancer
Xiongwei Deng et al.
BIOMATERIALS (2014)
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
Suzanne Richter et al.
INVESTIGATIONAL NEW DRUGS (2014)
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
Ana De Jesus-Acosta et al.
INVESTIGATIONAL NEW DRUGS (2014)
Coordinate Hyperactivation of Notch1 and Ras/MAPK Pathways Correlates with Poor Patient Survival: Novel Therapeutic Strategy for Aggressive Breast Cancers
Suruchi Mittal et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia
D. Koyama et al.
LEUKEMIA (2014)
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts
V. Agnusdei et al.
LEUKEMIA (2014)
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
F. Arruga et al.
LEUKEMIA (2014)
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel et al.
NATURE GENETICS (2014)
Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer
Y. Dai et al.
CELL DEATH & DISEASE (2014)
Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
Alexander Stoeck et al.
CANCER DISCOVERY (2014)
Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer
Giovanni Roti et al.
CANCER CELL (2013)
Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
Ming Qiu et al.
CANCER LETTERS (2013)
Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Anne F. Schott et al.
CLINICAL CANCER RESEARCH (2013)
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
Ivan Diaz-Padilla et al.
INVESTIGATIONAL NEW DRUGS (2013)
A Novel SERCA Inhibitor Demonstrates Synergy with Classic SERCA Inhibitors and Targets Multidrug-Resistant AML
Nicholas P. Bleeker et al.
MOLECULAR PHARMACEUTICS (2013)
Notch activation stimulates migration of breast cancer cells and promotes tumor growth
Victoria Bolos et al.
BREAST CANCER RESEARCH (2013)
β,β-Dimethylacrylshikonin exerts antitumor activity via Notch-1 signaling pathway in vitro and in vivo
Shao Zhen-Jun et al.
BIOCHEMICAL PHARMACOLOGY (2012)
γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer
H. Mizugaki et al.
BRITISH JOURNAL OF CANCER (2012)
A phase II study of RO4929097 in metastatic colorectal cancer
Jonathan R. Strosberg et al.
EUROPEAN JOURNAL OF CANCER (2012)
Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling
Yonggang Li et al.
FEBS JOURNAL (2012)
Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
Ian Krop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A Monoclonal Antibody against Human Notch1 Ligand-Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem-like Cells
Ankur Sharma et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Honokiol in Combination with Radiation Targets Notch Signaling to Inhibit Colon Cancer Stem Cells
Sivapriya Ponnurangam et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch
Desiree H. Floyd et al.
NEURO-ONCOLOGY (2012)
Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer
M. Kondratyev et al.
ONCOGENE (2012)
Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin
I. Hayashi et al.
ONCOGENE (2012)
Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch
James M. Haughian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Notch receptor-ligand binding and activation: Insights from molecular studies
Chandramouli R. Chillakuri et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma
Jingchun Sun et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Pathogenesis of CADASIL Transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3, in the cerebrovasculature
Anne Joutel
BIOESSAYS (2011)
Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
K. Pandya et al.
BRITISH JOURNAL OF CANCER (2011)
Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma
Min Kyu Kim et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
The Many Substrates of Presenilin/gamma-Secretase
Annakaisa Haapasalo et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia
Xin Xu et al.
MEDICAL ONCOLOGY (2011)
Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells
Sungpil Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2-and gamma-secretase inhibitors
Ana Silva et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Notch-1 Inhibition by Withaferin-A: A Therapeutic Target against Colon Carcinogenesis
Srinivas Koduru et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Therapeutic antibody targeting of individual Notch receptors
Yan Wu et al.
NATURE (2010)
Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors
Miguel Aste-Amezaga et al.
PLOS ONE (2010)
Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases
Ila Joshi et al.
BLOOD (2009)
Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells
S. Rasul et al.
BRITISH JOURNAL OF CANCER (2009)
Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
Leopoldo Luistro et al.
CANCER RESEARCH (2009)
MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
Yunqing Li et al.
CANCER RESEARCH (2009)
Notch-1 Signaling Is Lost in Prostate Adenocarcinoma and Promotes PTEN Gene Expression
Jarrett T. Whelan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Selective Use of ADAM10 and ADAM17 in Activation of Notch1 Signaling
Esra Cagavi Bozkulak et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Direct inhibition of the NOTCH transcription factor complex
Raymond E. Moellering et al.
NATURE (2009)
gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Pedro J. Real et al.
NATURE MEDICINE (2009)
The role of NOTCH1 signaling in T-ALL
A. A. Ferrando
Hematology-American Society of Hematology Education Program (2009)
A Notch1 ectodomain construct inhibits endothelial Notch signaling, tumor growth, and angiogenesis
Yasuhiro Funahashi et al.
CANCER RESEARCH (2008)
Therapeutic potential of gamma-secretase inhibitors and modulators
Bruno P. Imbimbo
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
The Notch pathway in prostate development and cancer
Kevin G. Leong et al.
DIFFERENTIATION (2008)
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
Ana Silva et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Delta-like 4 is indispensable in thymic environment specific for T cell development
Katsuto Hozumi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
C. Osipo et al.
ONCOGENE (2008)
Curcumin, both histone deacetylase and p300/CBP-Specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells
Yan Chen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Teresa Palomero et al.
NATURE MEDICINE (2007)
Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines
Takeaki Dohda et al.
EXPERIMENTAL CELL RESEARCH (2007)
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
Steven M. Chan et al.
BLOOD (2007)
Inhibition of D114-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion
Jeffrey S. Scehnet et al.
BLOOD (2007)
Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling
Huw D. Lewis et al.
CHEMISTRY & BIOLOGY (2007)
Notch signaling, gamma-secretase inhibitors, and cancer therapy
Ie-Ming Shih et al.
CANCER RESEARCH (2007)
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera-Troise et al.
NATURE (2006)
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Ridgway et al.
NATURE (2006)
The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
Tiffany M. Phillips et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc
Vishva Mitra Sharma et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Physiology and pathology of Notch signalling system
S Bianchi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Survival signaling by Notch1: Mammalian target of rapamycin (mTOR)-dependent inhibition of p53
Sathish Kumar Mungamuri et al.
CANCER RESEARCH (2006)
Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation
XD Wang et al.
DEVELOPMENTAL BIOLOGY (2006)
Notch and NOXA-related pathways in melanoma cells
BJ Nickoloff et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2005)
Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells
CL Curry et al.
ONCOGENE (2005)
High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival
M Reedijk et al.
CANCER RESEARCH (2005)
Inhibition of angiogenesis and tumor growth by β and γ-secretase inhibitors
D Paris et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Modulation of notch signaling elicits signature tumors and inhibits Hras1-induced oncogenesis in the mouse mammary epithelium
H Kiaris et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents
BJ Nickoloff et al.
ONCOGENE (2003)
Notch1 functions as a tumor suppressor in mouse skin
M Nicolas et al.
NATURE GENETICS (2003)
Delta4, an endothelial specific Notch ligand expressed at sites of physiological and tumor angiogenesis
C Mailhos et al.
DIFFERENTIATION (2001)
Presenilin-1 and-2 are molecular targets for γ-secretase inhibitors
D Seiffert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
